10-Q Filing

SOLENO THERAPEUTICS INC CIK: 1484565 Q2 2017

Filing Information

Form Type	10-Q
Accession Number	`0001628280-17-008596`
Period End Date	20170630
Filing Date	20170811
Fiscal Year	2017
Fiscal Period	Q2
XBRL Instance	capn-20170630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 64 Income Statement 80 Cash Flow Statement 80

Balance Sheet 64 line items

Line Item	Tag	Value	Unit	Period
Convertible preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Convertible preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.73M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.50M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.50M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$7.55M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$3.00K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$3.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	47.59M	shares	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalentsAtCarryingValue`	$35.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	16.79M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	16.79M	shares	Point-in-time
Inventory	`InventoryNet`	-	USD	Point-in-time
Inventory	`InventoryNet`	$164.00K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	47.59M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$246.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$247.00K	USD	Point-in-time
Current assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$790.00K	USD	Point-in-time
Current assets held for sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$2.32M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$10.32M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$3.80M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$53.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$54.00K	USD	Point-in-time
Other intangible assets, net	`OtherIntangibleAssetsNet`	$19.88M	USD	Point-in-time
Other intangible assets, net	`OtherIntangibleAssetsNet`	-	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$126.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$126.00K	USD	Point-in-time
Long-term assets held for sale	`DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent`	-	USD	Point-in-time
Long-term assets held for sale	`DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent`	$1.58M	USD	Point-in-time
Total assets	`Assets`	$30.38M	USD	Point-in-time
Total assets	`Assets`	$5.57M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.03M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$411.00K	USD	Point-in-time
Accrued compensation and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$1.05M	USD	Point-in-time
Accrued compensation and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$879.00K	USD	Point-in-time
Current liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$246.00K	USD	Point-in-time
Current liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$214.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.12M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.71M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$62.00K	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.13M	USD	Point-in-time
Long-term liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	$81.00K	USD	Point-in-time
Long-term liabilities held for sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	-	USD	Point-in-time
Total liabilities	`Liabilities`	$2.13M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.69M	USD	Point-in-time
Commitments and contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 8)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 47,587,647 and 16,786,952 shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively.	`CommonStockValue`	$48.00K	USD	Point-in-time
Common stock, $0.001 par value, 100,000,000 shares authorized, 47,587,647 and 16,786,952 shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively.	`CommonStockValue`	$17.00K	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$101.73M	USD	Point-in-time
Additional paid-in-capital	`AdditionalPaidInCapitalCommonStock`	$131.81M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-105.17M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-98.31M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$3.44M	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$26.69M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$5.57M	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$30.38M	USD	Point-in-time

Income Statement 80 line items

Line Item	Tag	Value	Unit	Period
Product revenue	`SalesRevenueNet`	$2.00K	USD	2 Qtrs
Product revenue	`SalesRevenueNet`	$2.00K	USD	1 Quarter
Product revenue	`SalesRevenueNet`	$4.00K	USD	2 Qtrs
Product revenue	`SalesRevenueNet`	$1.00K	USD	1 Quarter
Cost of product revenue	`CostOfRevenue`	$42.00K	USD	2 Qtrs
Cost of product revenue	`CostOfRevenue`	$69.00K	USD	2 Qtrs
Cost of product revenue	`CostOfRevenue`	$51.00K	USD	1 Quarter
Cost of product revenue	`CostOfRevenue`	$42.00K	USD	1 Quarter
Gross loss	`GrossProfit`	$-38.00K	USD	2 Qtrs
Gross loss	`GrossProfit`	$-41.00K	USD	1 Quarter
Gross loss	`GrossProfit`	$-49.00K	USD	1 Quarter
Gross loss	`GrossProfit`	$-67.00K	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.62M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$658.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.51M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$974.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$360.00K	USD	2 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$165.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	-	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$27.00K	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.21M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$3.27M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.19M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.42M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$5.26M	USD	2 Qtrs
Total expenses	`OperatingExpenses`	$2.25M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$3.17M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$4.75M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-2.29M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-4.79M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-3.21M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-5.32M	USD	2 Qtrs
Interest Income	`InterestIncomeOther`	$3.00K	USD	1 Quarter
Interest Income	`InterestIncomeOther`	-	USD	1 Quarter
Interest Income	`InterestIncomeOther`	-	USD	2 Qtrs
Interest Income	`InterestIncomeOther`	$4.00K	USD	2 Qtrs
Change in fair value of warrants liabilities income (expense)	`FairValueAdjustmentOfWarrants`	$101.00K	USD	2 Qtrs
Change in fair value of warrants liabilities income (expense)	`FairValueAdjustmentOfWarrants`	$-1.09M	USD	2 Qtrs
Change in fair value of warrants liabilities income (expense)	`FairValueAdjustmentOfWarrants`	$56.00K	USD	1 Quarter
Change in fair value of warrants liabilities income (expense)	`FairValueAdjustmentOfWarrants`	$32.00K	USD	1 Quarter
Cease-use expense	`GainLossOnContractTermination`	$-94.00K	USD	2 Qtrs
Cease-use expense	`GainLossOnContractTermination`	-	USD	1 Quarter
Cease-use expense	`GainLossOnContractTermination`	-	USD	1 Quarter
Cease-use expense	`GainLossOnContractTermination`	$-2.00K	USD	2 Qtrs
Other expense	`OtherNonrecurringExpense`	$16.00K	USD	1 Quarter
Other expense	`OtherNonrecurringExpense`	$18.00K	USD	2 Qtrs
Other expense	`OtherNonrecurringExpense`	-	USD	1 Quarter
Other expense	`OtherNonrecurringExpense`	$602.00K	USD	2 Qtrs
Interest and other income (expense), net	`OtherNonoperatingIncomeExpense`	$983.00K	USD	2 Qtrs
Interest and other income (expense), net	`OtherNonoperatingIncomeExpense`	$-29.00K	USD	1 Quarter
Interest and other income (expense), net	`OtherNonoperatingIncomeExpense`	$-72.00K	USD	1 Quarter
Interest and other income (expense), net	`OtherNonoperatingIncomeExpense`	$-701.00K	USD	2 Qtrs
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-4.34M	USD	2 Qtrs
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-2.37M	USD	1 Quarter
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-3.24M	USD	1 Quarter
Net loss from continuing operations	`IncomeLossFromContinuingOperations`	$-5.49M	USD	2 Qtrs
Net loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-2.36M	USD	2 Qtrs
Net loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-1.37M	USD	2 Qtrs
Net loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-1.15M	USD	1 Quarter
Net loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-727.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.97M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.51M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.70M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.86M	USD	2 Qtrs
Net loss per common share from continuing operations, basic and diluted (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.15	USD	1 Quarter
Net loss per common share from continuing operations, basic and diluted (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.14	USD	2 Qtrs
Net loss per common share from continuing operations, basic and diluted (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.29	USD	2 Qtrs
Net loss per common share from continuing operations, basic and diluted (in usd per share)	`IncomeLossFromContinuingOperationsPerBasicAndDilutedShare`	$-0.06	USD	1 Quarter
Net loss per common share from discontinued operations, basic and diluted (in usd per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare`	$-0.16	USD	2 Qtrs
Net loss per common share from discontinued operations, basic and diluted (in usd per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare`	$-0.07	USD	1 Quarter
Net loss per common share from discontinued operations, basic and diluted (in usd per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare`	$-0.01	USD	1 Quarter
Net loss per common share from discontinued operations, basic and diluted (in usd per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicAndDilutedShare`	$-0.03	USD	2 Qtrs
Net loss per share common share, basic and diluted (in usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.44	USD	2 Qtrs
Net loss per share common share, basic and diluted (in usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.17	USD	2 Qtrs
Net loss per share common share, basic and diluted (in usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.23	USD	1 Quarter
Net loss per share common share, basic and diluted (in usd per share)	`EarningsPerShareBasicAndDiluted`	$-0.07	USD	1 Quarter
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	15.16M	shares	2 Qtrs
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	53.06M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	15.53M	shares	1 Quarter
Weighted-average common shares outstanding used to calculate basic and diluted net loss per common share (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	40.03M	shares	2 Qtrs

Cash Flow Statement 80 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.97M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.51M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.70M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.86M	USD	2 Qtrs
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-2.36M	USD	2 Qtrs
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-1.37M	USD	2 Qtrs
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-1.15M	USD	1 Quarter
Loss from discontinued operations	`IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity`	$-727.00K	USD	1 Quarter
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-4.34M	USD	2 Qtrs
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-2.37M	USD	1 Quarter
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-3.24M	USD	1 Quarter
Loss from continuing operations	`IncomeLossFromContinuingOperations`	$-5.49M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$45.00K	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$570.00K	USD	2 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$443.00K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$628.00K	USD	2 Qtrs
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$218.00K	USD	1 Quarter
Stock-based compensation expense	`AllocatedShareBasedCompensationExpense`	$354.00K	USD	2 Qtrs
Loss on disposition of property & equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-1.00K	USD	2 Qtrs
Loss on disposition of property & equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	2 Qtrs
Board fees paid with common stock	`OtherNoncashExpense`	-	USD	2 Qtrs
Board fees paid with common stock	`OtherNoncashExpense`	$113.00K	USD	2 Qtrs
Change in fair value of common stock warrants	`ChangeInFairValueOfCommonStockWarrants`	$-1.12M	USD	2 Qtrs
Change in fair value of common stock warrants	`ChangeInFairValueOfCommonStockWarrants`	$159.00K	USD	2 Qtrs
Non-cash expense of issuing shares to Aspire Capital	`NoncashExpenseOnSharesIssued`	-	USD	2 Qtrs
Non-cash expense of issuing shares to Aspire Capital	`NoncashExpenseOnSharesIssued`	$602.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$2.00K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$670.00K	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$163.00K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-1.00K	USD	2 Qtrs
Prepaid expenses and other assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-12.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$78.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$270.00K	USD	2 Qtrs
Accrued compensation and other current liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-373.00K	USD	2 Qtrs
Accrued compensation and other current liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-193.00K	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$64.00K	USD	2 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-20.00K	USD	2 Qtrs
Net cash used in continuing operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-5.95M	USD	2 Qtrs
Net cash used in continuing operating activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.52M	USD	2 Qtrs
Net cash used in discontinued operating activities	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-1.43M	USD	2 Qtrs
Net cash used in discontinued operating activities	`CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations`	$-2.07M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-4.95M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.02M	USD	2 Qtrs
Costs of Essentialis acquisition paid	`PaymentsToAcquireBusinessesNetOfCashAcquired`	-	USD	2 Qtrs
Costs of Essentialis acquisition paid	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$223.00K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$20.00K	USD	2 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.00K	USD	2 Qtrs
Net cash used in continuing investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-20.00K	USD	2 Qtrs
Net cash used in continuing investing activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-227.00K	USD	2 Qtrs
Net cash used in discontinued investing activities	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$-5.00K	USD	2 Qtrs
Net cash used in discontinued investing activities	`CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations`	$-19.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-232.00K	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-39.00K	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$10.00M	USD	2 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$70.00K	USD	2 Qtrs
Net cash provided by continuing financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$10.00M	USD	2 Qtrs
Net cash provided by continuing financing activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$5.07M	USD	2 Qtrs
Net cash provided by discontinued financing activities	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	2 Qtrs
Net cash provided by discontinued financing activities	`CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations`	-	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.07M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$10.00M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-2.99M	USD	2 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$4.82M	USD	2 Qtrs
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.73M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$2.50M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$5.50M	USD	Point-in-time
Cash and cash equivalents, beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$7.55M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.73M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.50M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$5.50M	USD	Point-in-time
Cash and cash equivalents, end of period	`CashAndCashEquivalentsAtCarryingValue`	$7.55M	USD	Point-in-time
Conversion of Series A preferred to common stock	`ConversionOfStockAmountIssued1`	-	USD	2 Qtrs
Conversion of Series A preferred to common stock	`ConversionOfStockAmountIssued1`	$2.22M	USD	2 Qtrs
Issuance of common stock in Essentialis acquisition	`StockIssued1`	-	USD	2 Qtrs
Issuance of common stock in Essentialis acquisition	`StockIssued1`	$18.76M	USD	2 Qtrs
Costs of Essentialis acquisition included in accounts payable	`NoncashorPartNoncashAcquisitionValueofAssetsAcquiredButNotYetPaid`	$349.00K	USD	2 Qtrs
Costs of Essentialis acquisition included in accounts payable	`NoncashorPartNoncashAcquisitionValueofAssetsAcquiredButNotYetPaid`	-	USD	2 Qtrs
Contingent consideration of Essentialis acquisition	`NoncashorPartNoncashAcquisitionContingentConsideration`	$1.09M	USD	2 Qtrs
Contingent consideration of Essentialis acquisition	`NoncashorPartNoncashAcquisitionContingentConsideration`	-	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.